Nature Communications, Published online: 15 June 2026; doi:10.1038/s41467-026-73189-8 The regulatory roles of oncogenic KRAS in cell death pathways remain poorly understood. Here the authors report that KRAS induces a type I interferon response that primes pancreatic cancer cells for necroptosis, rendering a therapeutic vulnerability to inhibition of caspase 8.